Education
About Us
Working with TipRanks
Follow Us
Rocket Lab USA (RKLB)
NASDAQ:RKLB
RKLB Analyst Ratings
Strong Buy
9 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RKLB Stock 12 Month Forecast
Average Price Target
$30.20
▲(18.85%Upside)
| Highest Price Target$35.00 | Average Price Target$30.20 | Lowest Price Target$18.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$26
Hold
2.32%
Upside
Reiterated
06/14/25
Rocket Lab's overall stock score is driven by mixed financial performance and a challenging valuation, offset by strong earnings call outcomes and strategic corporate events. The company's focus on revenue growth and strategic initiatives provides a positive outlook, despite current profitability and cash flow challenges.
Cantor Fitzgerald
$29→$35
Buy
37.74%
Upside
Reiterated
06/10/25
Stifel Nicolaus
$34
Buy
33.81%
Upside
Reiterated
06/04/25
KeyBanc
$28→$29
Buy
14.13%
Upside
Reiterated
06/03/25
Deutsche Bank
$24→$27
Buy
6.26%
Upside
Reiterated
06/03/25
Citizens JMP
―
Hold
―
Reiterated
05/29/25
Roth MKM
$25→$35
Buy
37.74%
Upside
Reiterated
05/28/25
Bank of America Securities
$30
Buy
18.06%
Upside
Reiterated
05/28/25
TD Cowen
$29
Buy
14.13%
Upside
Reiterated
05/28/25
Needham
$28→$32
Buy
25.93%
Upside
Reiterated
05/28/25
Wells Fargo
$21→$18
Hold
-29.16%
Downside
Reiterated
04/08/25
Citi
$33
Buy
29.87%
Upside
Reiterated
04/01/25
Morgan Stanley
$20
Hold
-21.29%
Downside
Reiterated
03/10/25
Hold Rating on Rocket Lab USA Amid Neutron Program Delays and Market VolatilityWe view the push back to 2H25 as a relatively modest schedule shift and note some investors had been bracing for more significant delays heading into results. Encouragingly, the total projected cost to deliver the initial Neutron rocket (minimum viable product), per mgmt., remains within the $250-300mn range (~$200mn spent through 2024), while plans to operationalize a newly-acquired barge next year to enable landings at sea (monikered ‘Return on Investment’) reinforce reusability commitments. We are tweaking our PT for RKLB higher to $20 from $18 on better-than-expected 4Q24 results and lower outyear opex. expectations as RKLB exits its heavier Neutron investment period, while maintaining our Base Case range of $10-25 for the stock.
J.P. Morgan
$48→$45
Buy
77.10%
Upside
Reiterated
02/28/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$26
Hold
2.32%
Upside
Reiterated
06/14/25
Rocket Lab's overall stock score is driven by mixed financial performance and a challenging valuation, offset by strong earnings call outcomes and strategic corporate events. The company's focus on revenue growth and strategic initiatives provides a positive outlook, despite current profitability and cash flow challenges.
Cantor Fitzgerald
$29→$35
Buy
37.74%
Upside
Reiterated
06/10/25
Stifel Nicolaus
$34
Buy
33.81%
Upside
Reiterated
06/04/25
KeyBanc
$28→$29
Buy
14.13%
Upside
Reiterated
06/03/25
Deutsche Bank
$24→$27
Buy
6.26%
Upside
Reiterated
06/03/25
Citizens JMP
―
Hold
―
Reiterated
05/29/25
Roth MKM
$25→$35
Buy
37.74%
Upside
Reiterated
05/28/25
Bank of America Securities
$30
Buy
18.06%
Upside
Reiterated
05/28/25
TD Cowen
$29
Buy
14.13%
Upside
Reiterated
05/28/25
Needham
$28→$32
Buy
25.93%
Upside
Reiterated
05/28/25
Wells Fargo
$21→$18
Hold
-29.16%
Downside
Reiterated
04/08/25
Citi
$33
Buy
29.87%
Upside
Reiterated
04/01/25
Morgan Stanley
$20
Hold
-21.29%
Downside
Reiterated
03/10/25
Hold Rating on Rocket Lab USA Amid Neutron Program Delays and Market VolatilityWe view the push back to 2H25 as a relatively modest schedule shift and note some investors had been bracing for more significant delays heading into results. Encouragingly, the total projected cost to deliver the initial Neutron rocket (minimum viable product), per mgmt., remains within the $250-300mn range (~$200mn spent through 2024), while plans to operationalize a newly-acquired barge next year to enable landings at sea (monikered ‘Return on Investment’) reinforce reusability commitments. We are tweaking our PT for RKLB higher to $20 from $18 on better-than-expected 4Q24 results and lower outyear opex. expectations as RKLB exits its heavier Neutron investment period, while maintaining our Base Case range of $10-25 for the stock.
J.P. Morgan
$48→$45
Buy
77.10%
Upside
Reiterated
02/28/25
Best Analysts Covering Rocket Lab USA
1 Month
xxx
Success Rate
11/21 ratings generated profit
Average Return
+8.02%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.38% of your transactions generating a profit, with an average return of +8.02% per trade.
3 Months
xxx
Success Rate
9/15 ratings generated profit
Average Return
+21.10%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +21.10% per trade.
1 Year
Success Rate
12/15 ratings generated profit
Average Return
+133.07%
reiterated a buy rating 18 days ago
Copying Cai von Rumohr's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +133.07% per trade.
2 Years
xxx
Success Rate
15/15 ratings generated profit
Average Return
+283.17%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +283.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RKLB Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
3
8
9
6
1
Buy
11
14
16
22
20
Hold
3
7
7
9
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
29
32
37
25
Each month's total comprises the sum of three months' worth of ratings.
RKLB Financial Forecast
RKLB Stock Forecast FAQ
What is RKLB’s average 12-month price target, according to analysts?
Based on analyst ratings, Rocket Lab USA’s 12-month average price target is 30.20.
What is RKLB’s upside potential, based on the analysts’ average price target?
Rocket Lab USA has 18.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RKLB a Buy, Sell or Hold?
Rocket Lab USA has a consensus rating of Strong Buy which is based on 9 buy ratings, 3 hold ratings and 0 sell ratings.
What is Rocket Lab USA’s price target?
The average price target for Rocket Lab USA is 30.20. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $18.00. The average price target represents 18.85% Increase from the current price of $25.41.
The highest analyst price target is $35.00 ,the lowest forecast is $18.00. The average price target represents 18.85% Increase from the current price of $25.41.
What do analysts say about Rocket Lab USA?
Rocket Lab USA’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of RKLB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.